关注
Vinayak Bhandari
Vinayak Bhandari
Medical Biophysics, University of Toronto; Computational Biology, OICR
在 mail.utoronto.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1991*2020
Molecular landmarks of tumor hypoxia across cancer types
V Bhandari, C Hoey, LY Liu, E Lalonde, J Ray, J Livingstone, R Lesurf, ...
Nature genetics 51 (2), 308-318, 2019
5852019
Widespread and functional RNA circularization in localized prostate cancer
S Chen, V Huang, X Xu, J Livingstone, F Soares, J Jeon, Y Zeng, JT Hua, ...
Cell 176 (4), 831-843. e22, 2019
3812019
The evolutionary landscape of localized prostate cancers drives clinical aggression
SMG Espiritu, LY Liu, Y Rubanova, V Bhandari, EM Holgersen, LM Szyca, ...
Cell 173 (4), 1003-1013. e15, 2018
2482018
A prostate cancer “nimbosus”: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies
MLK Chua, W Lo, M Pintilie, J Murgic, E Lalonde, V Bhandari, ...
European urology 72 (5), 665-674, 2017
1842017
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open …
J Guinney, T Wang, TD Laajala, KK Winner, JC Bare, EC Neto, SA Khan, ...
The Lancet Oncology 18 (1), 132-142, 2017
1682017
Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer
L Yang, D Roberts, M Takhar, N Erho, BAS Bibby, N Thiruthaneeswaran, ...
EBioMedicine 31, 182-189, 2018
1502018
Divergent mutational processes distinguish hypoxic and normoxic tumours
V Bhandari, CH Li, RG Bristow, PC Boutros
Nature communications 11 (1), 737, 2020
1182020
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
S Cao, JR Wang, S Ji, P Yang, Y Dai, S Guo, MD Montierth, JP Shen, ...
Nature biotechnology 40 (11), 1624-1633, 2022
512022
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
MH Bailey, WU Meyerson, LJ Dursi, LB Wang, G Dong, WW Liang, ...
Nature communications 11 (1), 4748, 2020
442020
Quantifying the influence of mutation detection on tumour subclonal reconstruction
LY Liu, V Bhandari, A Salcedo, SMG Espiritu, QD Morris, T Kislinger, ...
Nature Communications 11 (1), 6247, 2020
23*2020
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
SB Coutts, S Ankolekar, R Appireddy, JF Arenillas, Z Assis, P Bailey, ...
The Lancet 403 (10444), 2597-2605, 2024
212024
Comparing continuous and discrete analyses of breast cancer survival information
V Bhandari, PC Boutros
Genomics 108 (2), 78-83, 2016
112016
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ...
nature genetics 55 (6), 1076-1076, 2023
22023
Author Correction: The evolutionary history of 2,658 cancers
M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ...
Nature 614 (7948), E42-E42, 2023
22023
Author Correction: Pan-cancer analysis of whole genomes
Nature 614 (7948), E39-E39, 2023
22023
Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
V Bhandari, CH Li, RG Bristow, PC Boutros
nature communications 13 (1), 7569, 2022
22022
Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer
S Cao, JR Wang, S Ji, P Yang, MD Montierth, S Guo, JP Shen, X Zhao, ...
bioRxiv, 2020.09. 30.306795, 2020
22020
Genomic evolution shapes prostate cancer disease type
DJ Woodcock, A Sahli, R Teslo, V Bhandari, AJ Gruber, A Ziubroniewicz, ...
Cell Genomics 4 (3), 2024
12024
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
WU Meyerson, LJ Dursi, LB Wang, G Dong, WW Liang, A Weerasinghe, ...
Nature Publishing Group UK, 2020
12020
系统目前无法执行此操作,请稍后再试。
文章 1–20